GlassScriptPhysician profile
Jason D Meade
NPI 1538597356
$3,291.00
in general payments reported to CMS, 2019-2025
17 companies · $39.33 in 2025
The $39.33 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).
See the full distribution for Urogynecology and Reconstructive Pelvic Surgery (Urology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $384 · 2021: $140 · 2022: $703 · 2023: $885 · 2024: $541 · 2025: $39.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,366 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,365.76 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $834.13 | 2023-2025 | Gemtesa |
| Laborie Medical Technologies Corp. | $448.45 | 2019-2024 | Eclipse |
| Urovant Sciences INC | $400.69 | 2022 | |
| Boston Scientific Corporation | $393.48 | 2020-2024 | Upsylon |
| Astellas Pharma US INC | $311.36 | 2019-2023 | Myrbetriq |
| Medtronic, INC. | $308.19 | 2022-2023 | Interstim |
| Medtronic USA, INC. | $192.23 | 2019 | |
| Axonics, INC. | $176.77 | 2020-2024 | Axonics |
| Pfizer INC. | $43.50 | 2019-2020 | |
| Intuitive Surgical, INC. | $34.01 | 2022-2024 | |
| Allergan, INC. | $30.31 | 2019 | |
| Amag Pharmaceuticals, INC. | $27.03 | 2019 | |
| Abbvie INC. | $23.08 | 2023 | |
| Mimedx Group, INC. | $22.48 | 2024 | |
| Rochester Medical Corporation | $17.71 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $15.01 | 2020 | |
| Sagent Pharmaceuticals | $12.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Meade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.